BioSpace News Archive

CollPlant Biotechnologies announced that Deputy CEO and CFO Eran Rotem will participate in investor conferences later this month.

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced the appointment of Richard L. Schilsky, MD, FASCO, FACP, FSCT to its Board of Directors, effective September 1, 2022.

Omega Therapeutics, Inc. (NASDAQ: OMGA) (“Omega”), today announced that management will participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference.

CSA Medical, Inc., today announced results from the first randomized, controlled study of Metered Cryospray (MCS) utilizing the RejuvenAir® System for the treatment of Chronic Bronchitis.

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) filing for investigational treatment NOV03 (perfluorohexyloctane).

Paraza Pharma Inc., a fully integrated drug discovery organization passionately committed to contributing to the life sciences sector announced the appointment of Dr. Sultan Ahmad as Chief Business Officer reporting to Dr. Arshad Siddiqui, founder and CEO of Paraza Pharma.

REGENXBIO Inc. announced it will participate in the following upcoming investor conferences.

Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 in New York City.

Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces that senior management will participate in the following investor conferences during September 2022:

Galderma has announced it will be showcasing its latest scientific updates at the 31st European Academy of Dermatology and Venereology congress in Milan, September 7-10, 2022.